Capital Flow Monitor · Sponsors · CIK 1673474
Convexity Scientific Inc.
c/o Convexity Scientific Inc., New Haven, CT, 006511 · 860-459-8177
Other Health Care · Corporation· inc. DELAWARE true
Fit score
—
Offering
$13.0M
Sold
$10.0M
% sold
77.0%
Investors
7
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-07 | D/A | 506(b) | $2.9M | $2.7M | 93.6% | 5 | EDGAR ↗ |
| 2026-08-07 | D ·current | 506(b) | $13.0M | $10.0M | 77.0% | 7 | EDGAR ↗ |
| 2026-03-02 | D | 506(b) | $2.5M | $613K | 24.5% | 2 | EDGAR ↗ |
| 2025-12-02 | D | 506(b) | $6.2M | $5.9M | 94.7% | 6 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Jennifer Barretta — Executive Officer, New Haven, CT
-
Kevin Rakin — Director, New Haven, CT
1 other raise
- Alphina Therapeutics, Inc. $154K of $10.0M · 1.5%
- Henry Weinstein — Director, New Haven, CT
-
Stephen Bruso — Director, New Haven, CT
2 other raises
- AdaptX, Inc. $2.7M of $4.6M · 58.5%
- Origin Medical Systems, Inc. $550K of $750K · 73.3%
- Mike Waters — Director, New Haven, CT
- Andrew Agwunobi — Director, New Haven, CT
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.